A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs

A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs

Lung adenocarcinoma (LUAD) is a malignant disease with an extremely poor prognosis, and there is currently a lack of clinical methods for early diagnosis and precise treatment and management. With the deepening of tumor research, more and more attention has been paid to the role of immune checkpoint...

Full description

Bibliographic Details
Main Authors: Yang Liu, Mingyang Yu, Xuechao Cheng, Xingshu Zhang, Qian Luo, Sijin Liao, Zhongzheng Chen, Jianhao Zheng, Kaijun Long, Xingwei Wu, Wendong Qu, Ming Gong, Yongxiang Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Genetics
Subjects:
lung adenocarcinoma
lncRNA
immune check point
tumor microenvironment
bioinformatic analyse
Online Access:https://www.frontiersin.org/articles/10.3389/fgene.2022.1016449/full

Internet

https://www.frontiersin.org/articles/10.3389/fgene.2022.1016449/full

Similar Items